Skip to main content
Clinical Trials/JPRN-UMIN000005540
JPRN-UMIN000005540CompletedPhase 2

Effect of Ezetimibe on visceral fat suppression in patients with chronic liver disease and hyperlipidemia ; a randomized, double blind, placebo-controlled, clinical trial - Effect of Ezetibmibe on viceral fat suppression in patients with chronic liver disease and hyperlipidemia.

Yokohama City University Medical Center Gastroenterological Center0 sites34 target enrollmentStarted: May 2, 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
34

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.Subjects during pregnancy, feeding, intimation of pregnancy or intended pregnancy 2.Subjects who have already treated with interferon and ribavirin 3.Subjects who have already treated with steroids, immunosuppressive agent, and antitumor agent. 4.Other,Subjects deemed unsuitable for the doctor

Investigators

Sponsor
Yokohama City University Medical Center Gastroenterological Center

Similar Trials